Product LOINCGENVA
Product Brief - HL7 V2 Implementation Guides: LOINCGENVA
Contents
back to Main_Page
back to Product_List
Product Name - V2 IG LOINCGENVA R1
HL7 Version 2 Implementation Guide: Clincial Genomics; Fully LOINC-Qualified Genetic Variation Model, Release 1 (US Realm)
Type
Informative (IG)
Releases
- HL7 V2 IG LOINCGENVA R1 Sept 2009
Summary
Supports the transmission of clinical genetic test results using a 2.5.1 lab message (from the lab to the medical record). Structured clinical genetic test results are key for clinical decision support, augmentation of patient data in clinical data warehouses, research studies, clinical trials, etc. For transmission of genetic test results, the HL7 Version 2 Implementation Guide uses models for already established standards for transmission of laboratory test results.
Business Case (Intended Use, Customers)
- Medical Record,
- Testing Laboratories,
- Clinical Research
Benefits
The main benefit is for current users of V2, that need an implementation guide based on established lab messaging specifications, for dissemination of genetic variation testing results.
Implementations/ Case Studies (Actual Users)
Resources
Ambassador Program by Grant Wood
Work Groups
Relationship to/ Dependencies on, other standards
- HL7 V2.5.1
- 2.5.1 Laboratory Result Implementation Guide,
- SNOMED,
- RxNORM, and
- LOINC
Links to current projects in development
- Project Insight ID # 196 Genetic Variation
